Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Safety and Tolerability Study of Neural Stem Cells (NR1) in Subjects With Chronic Ischemic Subcortical Stroke (ISS)
Sponsor: Gary Steinberg, MD, PhD
Summary
Evaluation of the safety and tolerability of escalating doses of NR1 administered intracerebrally at a single time-point post-injury to subjects with chronic ISS with or without cortical stroke.
Official title: A Phase 1/Phase 2a Safety and Tolerability Study of Intracerebral Transplantation of Neural Stem Cells (NR1) in Subjects With Chronic Ischemic Subcortical Stroke (ISS) and Early Evaluation of Potentially Useful Efficacy Parameters
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2021-01-04
Completion Date
2029-08-31
Last Updated
2025-03-20
Healthy Volunteers
No
Conditions
Interventions
Neural Stem Cells
NR1 is a human embryonic stem cell (hESC) derived product for the treatment of chronic ischemic subcortical stroke
Locations (1)
Stanford Health Center
Stanford, California, United States